Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 452,839Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 11Inlyta

PharmaCompass

01

Brand Name : Inlyta

Axitinib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Inlyta

arrow
Indo Livestock Expo
Not Confirmed

Axitinib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 477

2018 Revenue in Millions : 298

Growth (%) : 60

blank

02

Brand Name : Inlyta

Axitinib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Inlyta

arrow
Indo Livestock Expo
Not Confirmed

Axitinib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 787

2019 Revenue in Millions : 477

Growth (%) : 65

blank

03

Brand Name : Inlyta

Axitinib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Inlyta

arrow
Indo Livestock Expo
Not Confirmed

Axitinib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 1,002

2020 Revenue in Millions : 787

Growth (%) : 27

blank

04

Brand Name : Inlyta

Axitinib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Inlyta

arrow
Indo Livestock Expo
Not Confirmed

Axitinib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 1,003

2021 Revenue in Millions : 1,002

Growth (%) : 0

blank

05

Brand Name : Inlyta

Axitinib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Inlyta

arrow
Indo Livestock Expo
Not Confirmed

Axitinib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 1,036

2022 Revenue in Millions : 1,003

Growth (%) : 3

blank

06

Brand Name : Inlyta

Axitinib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Inlyta

arrow
Indo Livestock Expo
Not Confirmed

Axitinib

Main Therapeutic Indication : Oncology

Currency : USD

2024 Revenue in Millions : 978

2023 Revenue in Millions : 1,036

Growth (%) : -6

blank

07

Brand Name : Inlyta

Axitinib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Inlyta

arrow
Indo Livestock Expo
Not Confirmed

Axitinib

Main Therapeutic Indication : Oncology

Currency : USD

2014 Revenue in Millions : 28.80%

2013 Revenue in Millions :

Growth (%) :

blank

08

Brand Name : Inlyta

Axitinib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Inlyta

arrow
Indo Livestock Expo
Not Confirmed

Axitinib

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 410

2014 Revenue in Millions : 430

Growth (%) : 5%

blank

09

Brand Name : Inlyta

Axitinib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Inlyta

arrow
Indo Livestock Expo
Not Confirmed

Axitinib

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 401

2015 Revenue in Millions : 430

Growth (%) : -7

blank

10

Brand Name : Inlyta

Axitinib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Inlyta

arrow
Indo Livestock Expo
Not Confirmed

Axitinib

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 339

2016 Revenue in Millions : 401

Growth (%) : -15

blank